Return to play (RTP) has recently gained a lot of attention due to some shocking statistics, such as that only 55% of athletes return to competitive sports following an anterior cruciate ligament reconstruction (Ardern, CL et al, BJSM 2014). In the end, it is all about Return to Play and the only question doctors, players and teams seem to care about is “when will the player be back on the field safely?”. However, the main problem is that RTP decisions are in most cases still based on prediction and not on the basis of muscle status in a given time. The main reason for that is that imaging and similar methods for the diagnostics of structural muscle injuries do not provide useful information in later stages when muscle structure recovers, while muscle function stays impaired. As a consequence, athletes are exposed to high loads too early, which in most cases leads to re-injury. That is why more functional tests such as TMG should be included in RTP protocols, as only then it can be precisely determined when a certain muscle can be re-exposed to maximal loads. You can learn more about the benefits of TMG for RTP at our workshop at the Isokinetic Conference that will be held in the beginning of April in London.